Physician profile

Clay M Barbin

Interventional Cardiology · Waco, TX

NPI 1659715696

$11,020.86

in general payments reported to CMS, 2019-2025

39 companies · $1,445 in 2025

The $1,445 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,039.29

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $2,831.98 2019-2025 Avvigo Guidance System, Lux-Dx Insertable Cardiac Monitor, Farapulse
Medtronic Vascular, INC. $2,520.25 2019-2020
Medtronic, INC. $1,080.87 2021-2024 Corevalve Evolut R, Symplicity G3, Onyx Frontier
Abbott Laboratories $957.56 2019-2025 Thoratec Heartmate 3 Lvas Implant Kit, Dragonfly Opstar, Cardiomems
Astrazeneca Pharmaceuticals LP $422.40 2020-2025 Farxiga, Lokelma
Abiomed $402.46 2022-2025 Impella
Inari Medical, INC. $311.45 2021-2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Cleerly, INC. $289.24 2025 Cleerly Labs, Cleerly Ischemia
Shockwave Medical, INC $280.69 2020-2024 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Edwards Lifesciences Corporation $249.25 2019-2023 Sapien 3 Ultra Resilia
Novartis Pharmaceuticals Corporation $239.55 2021-2024
Arineta, INC $166.27 2023 Cardiographe
W. L. Gore & Associates, INC. $140.54 2019
Penumbra, INC. $136.60 2025 Indigo System
Impulse Dynamics (USA) INC. $130.81 2022
Show all 39 companies
CompanyGeneral paymentsYearsTop products
E.R. Squibb & Sons, L.L.C. $125.44 2019-2025 Camzyos, Eliquis
Boehringer Ingelheim Pharmaceuticals, INC. $103.02 2023-2025 Jardiance
Amgen INC. $91.64 2021-2023 Repatha
Merck Sharp & Dohme LLC $39.83 2022
Alnylam Pharmaceuticals INC. $39.78 2025 Onpattro
Novo Nordisk INC $36.12 2024-2025 Ozempic, Rybelsus
Pfizer INC. $35.21 2021-2022
Bard Peripheral Vascular, INC. $34.75 2025 Rotarexs 6 F X 135 Cm
Bracco Diagnostics INC. $30.14 2025
Teleflex LLC $29.00 2019-2025 Orsiro Mission
Scpharmaceuticals INC. $28.75 2024-2025
Angiodynamics, INC. $24.79 2022
Philips North America LLC $24.64 2021
Cardiva Medical, INC. $24.27 2023 Cardiva Vascade 6/7f Vcs
Heartflow, INC. $23.91 2024
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $23.49 2022
Kiniksa Pharmaceuticals International, Plc $21.81 2024 Arcalyst
Cardiovascular Systems INC. $21.45 2021
Actelion Pharmaceuticals US, INC. $18.14 2023 Uptravi
Kiniksa Pharmaceuticals, LTD. $17.94 2021
Esperion Therapeutics, INC. $17.62 2021
Terumo Medical Corporation $16.72 2019
Biosense Webster, INC. $16.61 2021
Janssen Pharmaceuticals, INC $15.87 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Clay M Barbin

$11,020.86

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $1,445 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/2793306/clay-m-barbin

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.